CCL3 and glioblastoma: Pre-conditioning the vaccine site with a potent recall antigen (e.g., tetanus/diphtheria toxoid) significantly enhances DC migration bilaterally and improves the survival of glioblastoma patients, and this phenomenon is dependent on the chemokine CCL3 in murine models 122.